YY2 overexpression significantly reduced the tumorigenic potential of HCC‐LM3 cells, whereas DRP1 overexpression restored it (Figure8A; Figure S16B, Supporting Information). This evidence concerns the gene YY2 and hepatocellular carcinoma.